Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
With the slowdown in world economic growth, the Allergy Immunotherapies (Allergy Immunotherapy) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Allergy Immunotherapies (Allergy Immunotherapy) market size to maintain the average annual growth rate of 0.0745208058321 from 740.0 million $ in 2014 to 1060.0 million $ in 2019, Stratagem Market Insights analysts believe that in the next few years, Allergy Immunotherapies (Allergy Immunotherapy) market size will be further expanded, we expect that by 2026, The market size of the Allergy Immunotherapies (Allergy Immunotherapy) will reach 1670.0 million $.
Market Overview ╼
Allergen immunotherapy is a medical treatment practiced for environmental allergies such as asthma and insect bites. Immunotherapy includes exposing patients to larger and larger amounts of allergen, in order to change the immune system’s response. Its benefits for food-related allergies are not clear and hence not recommended. Different studies have found that injection of allergens under the skin is effective in treating allergic rhinitis in children and in asthma. The global allergen immunotherapies (allergen immunotherapy) market focuses on six regions namely North America, South America, Europe, Asia Pacific, Middle East, and Africa. The global allergen immunotherapies (allergen immunotherapy) market is expected to witness significant growth during the forecast period, owing to the increasing number of patients suffering from different types of surgeries.
Market Driver ╼
An increasing number of allergy cases around the globe combined with increasing cases of asthma are expected to drive the growth of the global allergen immunotherapies (allergen immunotherapy) market during the forecast period. According to the American Academy of Allergy Asthma & Immunology (AAAAI), globally allergic rhinitis affects between 10% and 30% of the population. Furthermore, according to the World Health Organization (WHO), in November 2019, around 235 million people are living with asthma. According to the same source, around 80% of asthma-related deaths occur in emerging economies. Hence, the growing prevalence of asthma and allergy-related diseases are expected to drive market growth during the forecast period. Moreover, the availability of novel immunotherapies is expected to propel the global allergen immunotherapies (allergen immunotherapy) market growth over the forecast period.
Market Restraint ╼
Lack of awareness regarding allergy and treatments, especially in emerging economies, is expected to restrain the growth of the global allergen immunotherapies (allergen immunotherapy) market over the forecast period.
Regional Insight ╼
Among regions, North America is expected to witness significant growth in the global allergen immunotherapies (allergen immunotherapy) market during the forecast period. This is owing to the high prevalence of allergies and strict regulatory guidelines mandating allergic testing in the region. Moreover, Asia Pacific is expected to exhibit a lucrative growth rate over the forecast period, owing to increasing incidents of infectious diseases and improving healthcare infrastructure in the region.
Competitive Landscape ╼
Key players operating in the global allergen immunotherapies (allergen immunotherapy) market are ALK-Abello, HAL, Leti, Stallergenes Greer, Hollister Stier, Merck, WOLW Pharma, and Allergy Therapeutics.
Key companies in the market are focused on gaining product approval from regulatory authorities, in order to enhance their market presence. For instance, in June 2019, ALK-Abello received marketing approval for its tree sublingual allergy immunotherapy (SLIT) tablet ‘ITULAZAX’ in 17 European countries.
This Report covers the manufacturers' data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume, and value, as well as price data.
Besides, the report also covers segment data, including type segment, industry segment, channel segment, etc. cover different segment market sizes, both volume, and value. It also covers different industries' clients information, which is very important for manufacturers. If you need more information,
Section 1: Definition
Section (2 3): Manufacturer Detail
➟ ALK-Abello
➟ Stallergenes Greer
➟ Merck
➟ Allergy Therapeutics
➟ HAL
➟ WOLW Pharma
➟ Holister Stier
➟ Leti
Section 4: Region Segmentation
➟ North America Country (United States, Canada)
➟ South America
➟ Asia Country (China, Japan, India, Korea)
➟ Europe Country (Germany, UK, France, Italy)
➟ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation ➟
╼ Subcutaneous Immunotherapy
╼ Sublingual Immunotherapy
Industry Segmentation ➟
╼ Allergic Rhinitis
╼ Allergic Asthma
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
